Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

DOI Web Site 1 Citations

M. Hardy-Werbin

Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
O. Arpí

Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
A. Taus

Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain
P. Rocha

Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain
D. Joseph-Pietras

NIHR Experimental Cancer Medicine Centre, Southampton, United Kingdom
L. Nolan

Medical Oncology Department, University Hospital Southampton, Southampton, United Kingdom
S. Danson

Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, United Kingdom
R. Griffiths

Medical Oncology Department, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom
M. Lopez-Botet

Immunology unit, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
A. Rovira

Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
J. Albanell

Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
C. H. Ottensmeier

Cancer Science Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
E. Arriola

Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

Journal

Back to top